Market Access/ News/ News Amicus’ oral Fabry disease drug approved in US Richard Staines Amicus Therapeutics, Fabry disease, FDA approval, Galafold, rare disease 0 Comment Decision follows approval in Europe Share X Amicus’ oral Fabry disease drug approved in US https://pharmaphorum.com/news/amicus-oral-fabry-disease-drug-approved/
News/ Rare diseases Amicus to file Fabry drug after FDA changes mind Richard Staines Amicus Therapeutics, fda, Rare diseases, regulation, Sanofi, Shire 0 Comment Regulator drops demand for further phase 3 trial. Share X Amicus to file Fabry drug after FDA changes mind https://pharmaphorum.com/news/amicus-therapeutics-fabry-drug-us-fda-changes-mind/
News/ Pharma Market Access/ Sales and Marketing/ UK & Europe Amicus set for share of Fabry market after NICE approval Andrew McConaghie Amicus Therapeutics, Fabry disease, NICE, Rare diseases 0 Comment England and Wales’ cost effectiveness watchdog NICE has given a final recommendation to a new treatment for the Share X Amicus set for share of Fabry market after NICE approval https://pharmaphorum.com/news/amicus-set-share-fabry-market-nice-approval/